AI Insight
Researchers are exploring the use of bacteriophages (viruses that naturally infect bacteria) as a novel cancer treatment approach by genetically engineering them to target and destroy cancer cells. The innovative aspect involves leveraging existing immunity that people have developed from previous vaccinations to enhance the anti-cancer response. This strategy repurposes the body's established immune memory to recognize and attack tumor cells tagged by the modified phages.
Why it matters
This approach could provide a new avenue for cancer immunotherapy that builds upon the widespread vaccine immunity in populations, potentially offering a safer and more effective treatment option. By using the body's pre-existing immune responses rather than requiring new immunizations, this method could accelerate treatment timelines and reduce the need for immune system priming.
Understand the Science
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from vaccines
Source: Phages could enable us to hijack vaccine immunity to kill cancer cells